Raymond James Financial Services Advisors’s Dare Bioscience DARE Stock Holding History

Raymond James Financial Services Advisors’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,667	Closed	-$6.72K	–	3467
2024 Q2	$6.72K	Hold	1,667	–	–	﹤0.01%	3383
2024 Q1	$9.8K	Sell	1,667 -632	-27%	-$3.1K	﹤0.01%	3368
2023 Q4	$8.53K	Buy	2,299 +632	+38%	+$2.89K	﹤0.01%	3268
2023 Q3	$9.24K	Sell	1,667 -1	-0.1%	-$8	﹤0.01%	3230
2023 Q2	$18.2K	Buy	1,668 +1	+0.1%	+$12	﹤0.01%	3178
2023 Q1	$20.8K	Sell	1,667 -833	-33%	-$11.1K	﹤0.01%	3176
2022 Q4	$24.9K	Hold	2,500	–	–	﹤0.01%	3138
2022 Q3	$30K	Hold	2,500	–	–	﹤0.01%	3137
2022 Q2	$37K	Hold	2,500	–	–	﹤0.01%	3109
2022 Q1	$45K	Hold	2,500	–	–	﹤0.01%	3202
2021 Q4	$60K	Buy	+2,500	New	+$51.4K	﹤0.01%	3166

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FFS

Founders Financial Securities Towson, Maryland $1.95B AUM 22.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Raymond James Financial Services Advisors's DARE Position: Q3 2024 in Review

Raymond James Financial Services Advisors sold out of Dare Bioscience (DARE) in Q3 2024, closing a stake of 1,667 shares — an estimated $6.72K sold.

Raymond James Financial Services Advisors first reported a position in DARE in Q4 2021 and held it in 11 quarters. The position peaked at $60K in Q4 2021. 22 funds tracked by Wall St. Rank hold DARE as of Q3 2024.

Raymond James Financial Services Advisors reported no remaining Dare Bioscience position as of Q3 2024 after selling out during the quarter.
Raymond James Financial Services Advisors sold 1,667 Dare Bioscience shares in Q3 2024, an estimated $6.72K.
Raymond James Financial Services Advisors first reported a position in Dare Bioscience in Q4 2021 and held it in 11 quarters.
Raymond James Financial Services Advisors's Dare Bioscience position peaked at $60K in Q4 2021.
22 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.